Heart Failure with Preserved Ejection Fraction (HFpEF) Latest Advances

Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Published: December 03, 2025

Age-adjusted Trends in the Diastolic and Systolic Heart Failure in the United States Over Recent Years Based on Race and Gender, With Higher Trends in Men and African Americans.

Journal: Critical pathways in cardiology

Published: December 01, 2025

GATA3 and IFNG as Potential Molecular Biomarkers for Differentiating Heart Failure with Preserved Ejection Fraction with Normal Versus Elevated BNP Levels.

Journal: International heart journal

Published: November 30, 2025

Geometry over thickness: Refining echocardiographic recognition of amyloid cardiomyopathy.

Journal: Progress in cardiovascular diseases

Published: November 29, 2025

Limited Ventilatory Reserve During Exercise in Heart Failure with Preserved Ejection Fraction: Impact of Lung Size and Adiposity.

Journal: CHEST pulmonary

Published: November 28, 2025

Filters

Correlation between Serum Uric Acid Level and Left Ventricular Ejection Fraction in Patients with Heart Failure.

Correlation between Serum Uric Acid Level and Left Ventricular Ejection Fraction in Patients with Heart Failure.

A Once-Weekly C-Type Natriuretic Peptide for Treatment of Heart Failure with Preserved Ejection Fraction.

A Once-Weekly C-Type Natriuretic Peptide for Treatment of Heart Failure with Preserved Ejection Fraction.

Targeting Metabolic Dysfunction and Inflammation with Sotagliflozin Reverses Diastolic Dysfunction in Experimental HFpEF.

Targeting Metabolic Dysfunction and Inflammation with Sotagliflozin Reverses Diastolic Dysfunction in Experimental HFpEF.

Glucagon-Like Peptide-1 Receptor Agonists Versus Bariatric Surgery in Patients With Obesity and Heart Failure With Preserved Ejection Fraction.

Glucagon-Like Peptide-1 Receptor Agonists Versus Bariatric Surgery in Patients With Obesity and Heart Failure With Preserved Ejection Fraction.

Study Protocol for HeartMagic: A Prospective Observational Cohort Characterizing Subtypes of Heart Failure With Preserved Ejection Fraction.

Study Protocol for HeartMagic: A Prospective Observational Cohort Characterizing Subtypes of Heart Failure With Preserved Ejection Fraction.

Epigenetic Aging Clocks and Incident Cardiovascular Outcomes: Results From the MESA.

Epigenetic Aging Clocks and Incident Cardiovascular Outcomes: Results From the MESA.

Empagliflozin and Dapagliflozin Outcomes in Heart Failure.

Empagliflozin and Dapagliflozin Outcomes in Heart Failure.

Effect of Abnormal Calcium Dynamics on Heart Failure based on a Biophysical Modeling Study.

Effect of Abnormal Calcium Dynamics on Heart Failure based on a Biophysical Modeling Study.

Age-adjusted Trends in the Diastolic and Systolic Heart Failure in the United States Over Recent Years Based on Race and Gender, With Higher Trends in Men and African Americans.

Age-adjusted Trends in the Diastolic and Systolic Heart Failure in the United States Over Recent Years Based on Race and Gender, With Higher Trends in Men and African Americans.

GATA3 and IFNG as Potential Molecular Biomarkers for Differentiating Heart Failure with Preserved Ejection Fraction with Normal Versus Elevated BNP Levels.

GATA3 and IFNG as Potential Molecular Biomarkers for Differentiating Heart Failure with Preserved Ejection Fraction with Normal Versus Elevated BNP Levels.

Geometry over thickness: Refining echocardiographic recognition of amyloid cardiomyopathy.

Geometry over thickness: Refining echocardiographic recognition of amyloid cardiomyopathy.

Limited Ventilatory Reserve During Exercise in Heart Failure with Preserved Ejection Fraction: Impact of Lung Size and Adiposity.

Limited Ventilatory Reserve During Exercise in Heart Failure with Preserved Ejection Fraction: Impact of Lung Size and Adiposity.